Last updated on July 2018

Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease

Brief description of study

A randomized multicentric study for endovascular treatment of patients with obstructive disease in the SFA (superficial femoral artery) and in the popliteal artery.

Detailed Study Description

This interventional study will collect data about the treatment of de novo lesions or restenotic lesions. Restenotic lesions that are previously DCB (drug coated balloon) treated or in-stent restenosis are excluded in this study.

The primary objective of this randomized study is to compare the efficacy of the DCB (Legflow

  • Cardionovum) versus POBA for the treatment of de novo lesions or restenosis in the SFA and in the popliteal artery (segment P1 -P2) by assessing the binary restenosis rate with duplex ultrasonography at 12 months.

The secondary endpoints are the assessment of the immediate procedural outcome, distribution of Rutherford, mortality, target lesion revascularization (TLR), target extremity revascularization (TER), amputation and anklebrachial index (ABI).

For each patient enrolled, data will be collected up to 12 months after the procedure.

Clinical Study Identifier: NCT02710656

Contact Investigators or Research Sites near you

Start Over

Peter Goverde, Dr

ZNA Stuivenberg
Antwerpen, Belgium
  Connect »

Jan De Letter, Dr.

AZ Sint-Jan
Brugge, Belgium
  Connect »

Geert Lauwers, Dr.

ZOL (Ziekenhuis Oost-Limburg)
Genk, Belgium
  Connect »

Jos Vandekerkhof, Dr.

Jessa hospital
Hasselt, Belgium
  Connect »

Inge Fourneau, Prof. Dr.

UZ Leuven
Leuven, Belgium
  Connect »

Eric Ducasse, Prof. Dr.

CHU Bordeaux
Bordeau, France
  Connect »

Eugenio Rosset, Prof. Dr.

CHU Cermont-Ferrand
Clermont-Ferrand, France
  Connect »

Mathieu Poirier, Dr.

CH Mont-de-Marsan
Mont-de-Marsan, France
  Connect »

Michael Lichtenberg, Dr.

Klinikum Arnsberg
Arnsberg, Germany
  Connect »